Filing Flows

Filing Flows › Editas Medicine (EDIT) › Who owns the stock

Who owns Editas Medicine (EDIT) stock

200 funds reported Editas Medicine (EDIT) shares in their latest 13F filings, worth $395M in all. The largest holder is TCG Crossover Management, LLC ($36.0M). Last quarter 104 funds added to their stakes and 56 cut them.

Largest holders of EDIT (13F)Largest holders of EDIT (13F)TCG Crossover Management, LLC$36.0MBlackRock$34.3MRA Capital Management, L.P.$28.8MADAR1 Capital Management, LLC$28.8MCommodore Capital LP$28.8MVanguard Capital Management LLC$19.9MParadigm Biocapital Advisors LP$18.1MVanguard Group$16.8MOpaleye Management$12.5MVanguard Portfolio Management LLC$11.7M

Largest holders (13F)

FundSharesValueChangeQuarter
TCG Crossover Management, LLC11,111,111$36.0Mnew2026-06-30
BlackRock10,589,990$34.3Mincrease2026-06-30
RA Capital Management, L.P.8,889,000$28.8Mnew2026-06-30
ADAR1 Capital Management, LLC8,889,000$28.8Mnew2026-06-30
Commodore Capital LP8,889,000$28.8Mnew2026-06-30
Vanguard Capital Management LLC6,141,336$19.9Mincrease2026-06-30
Paradigm Biocapital Advisors LP5,586,625$18.1Mnew2026-06-30
Vanguard Group8,208,068$16.8Mincrease2025-12-31
Opaleye Management3,861,930$12.5Mincrease2026-06-30
Vanguard Portfolio Management LLC3,598,339$11.7Mincrease2026-06-30
Woodline Partners LP3,555,497$11.5Mnew2026-06-30
Vivo Capital, LLC3,555,250$11.5Mnew2026-06-30
GordonMD Global Investments LP3,127,000$10.1Mnew2026-06-30
Goldman Sachs Group2,614,036$8.5Mincrease2026-06-30
Geode Capital Management, LLC2,569,072$8.3Mincrease2026-06-30

Editas Medicine's latest quarter

Editas Medicine, Q2 2026: revenue $11.9M (+232% year over year), operating margin -156.0%, net loss $18.2M, operating cash flow −$29.6M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most EDIT stock?

By the latest 13F filings: TCG Crossover Management, LLC ($36.0M); BlackRock ($34.3M); RA Capital Management, L.P. ($28.8M); ADAR1 Capital Management, LLC ($28.8M); Commodore Capital LP ($28.8M).

What is the short interest in EDIT?

38,185,007 shares were sold short at the 2026-10-15 settlement, 2.9% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.